GlaxoSmithkline Consumer Healthcare has informed that a meeting of the Board of Directors of the Company will be held on November 05, 2014, to consider and take on record the Un-audited Financial Results for the quarter ended September 30, 2014 (Q2) with Limited Review done by the Statutory Auditors.
The above information is a part of company’s filings submitted to BSE.